Creative Destruction Lab brings together ventures and entrepreneurs to Oxford for the first CDL-Oxford session
18 November 2019
The Creative Destruction Lab (CDL) is a seed-stage program for massively scalable science and technology-based companies. The program uses an objective-based mentoring system to maximize equity-value creation.
Launched in 2012 at the Rotman School of Management at the University of Toronto, the program has expanded from 5 locations in Northern America to Oxford (Saïd Business School) and most recently, Paris (HEC Paris). CDL is particularly well suited for early-stage companies with links to university research labs.
The program involves intensive full-day sessions and mentorship from select entrepreneurs and angel investors, known as the CDL Fellows and Associates. These intensive one-day sessions take place every eight weeks, to assess the progress of the ventures and to set new short-term objectives.
CDL-Oxford launched the first of these intense day-long sessions on November 15, inviting over 60 mentors to Saïd Business School to give advice to 26 Artificial Intelligence (AI) companies, who were chosen from a pool of over 270 applicants. These companies all focus on advancing the technology of AI itself or using AI in an innovative way in a wide variety of industries, including health, construction, finance and media. Ventures who make it through the first stage will be invited to join the mentors for a second session in January 2020 and over the next 9 months, the mentors will help the ventures set measured objectives to help them massively scale their ventures with a series of 8-week targets.
The session started with a launch dinner on November 14 at the Divinity School to welcome the accomplished mentors to Oxford. Welcoming talks were given by Professor Sir Nigel Shadbolt, Professor Ajay Agrawal (University of Toronto) and Elizabeth Caley (Chan-Zuckerberg Initiative), seen above speaking on the importance of Ethics in applications of AI.
For more information about the CDL-Oxford program, please contact Dr James Semple